Musher DM |
Clarithromycin therapy for Mycobacterium avium complex bacteremia. |
1995 |
Ann. Intern. Med. |
pmid:7778830
|
van der Meer JT and Danner SA |
Clarithromycin therapy for Mycobacterium avium complex bacteremia. |
1995 |
Ann. Intern. Med. |
pmid:7778831
|
Steinman MA et al. |
Changing use of antibiotics in community-based outpatient practice, 1991-1999. |
2003 |
Ann. Intern. Med. |
pmid:12667022
|
Singh N and Yu VL |
Clarithromycin therapy for Mycobacterium avium complex bacteremia. |
1995 |
Ann. Intern. Med. |
pmid:7632282
|
Wallace RJ et al. |
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. |
1993 |
Ann. Intern. Med. |
pmid:8357113
|
Neu HC |
New macrolide antibiotics: azithromycin and clarithromycin. |
1992 |
Ann. Intern. Med. |
pmid:1310839
|
De Francesco V et al. |
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. |
2006 |
Ann. Intern. Med. |
pmid:16418408
|
Yang YJ et al. |
Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes. |
2017 |
Ann. Med. |
pmid:28266875
|
Trotti LM et al. |
Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial. |
2015 |
Ann. Neurol. |
pmid:26094838
|
Ferreri AJ et al. |
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial. |
2015 |
Ann. Oncol. |
pmid:25935794
|
Di Raimondo F et al. |
Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma? |
2007 |
Ann. Oncol. |
pmid:17065587
|
Rhee CS et al. |
Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. |
2000 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10823478
|
Heffernan CB et al. |
Does Clarithromycin Cause Hearing Loss? A 12-Year Review of Clarithromycin Therapy for Nontuberculous Mycobacterial Lymphadenitis in Children. |
2018 |
Ann. Otol. Rhinol. Laryngol. |
pmid:30032669
|
Clifford K et al. |
Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. |
1999 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10214783
|
Mullin D et al. |
Mycobacterium chelonae infections involving the head and neck. |
2009 |
Ann. Otol. Rhinol. Laryngol. |
pmid:19894399
|
Callaghan R and Allen M |
Mycobacterium malmoense infection of the knee. |
2003 |
Ann. Rheum. Dis. |
pmid:14583565
|
Hiramatsu M et al. |
Risk factors that affect the surgical outcome in the management of focal bronchiectasis in a developed country. |
2012 |
Ann. Thorac. Surg. |
pmid:22119119
|
Fan X et al. |
Lung perfusion with clarithromycin ameliorates lung function after cardiopulmonary bypass. |
2006 |
Ann. Thorac. Surg. |
pmid:16488691
|
Nelson KG et al. |
Results of operation in Mycobacterium avium-intracellulare lung disease. |
1998 |
Ann. Thorac. Surg. |
pmid:9725364
|
Kadir IS et al. |
Recurrent acute rheumatic fever: a forgotten diagnosis? |
2004 |
Ann. Thorac. Surg. |
pmid:15276555
|
Bossert T et al. |
Successful management of two heart transplant recipients with mycobacterial pulmonary infections. |
2005 |
Ann. Thorac. Surg. |
pmid:16039241
|
Watanabe M et al. |
Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones. |
2006 |
Ann. Thorac. Surg. |
pmid:16731124
|
Gintovt EA |
[Use of clarithromycin in the treatment of atopic dermatitis complicated by staphylococcal infection]. |
2004 |
Antibiot. Khimioter. |
pmid:15164520
|
Vasil'ev IuV and Zvenigorodskaia LA |
[Fromilide (clarithromycin) in eradication of Helicobacter pylori in patients with duodenal ulcer]. |
2002 |
Antibiot. Khimioter. |
pmid:12365323
|
Iakovlev EA et al. |
[Present stage of chemotherapy and chemoprophylaxis of rickettsiosis and Q fever]. |
2011 |
Antibiot. Khimioter. |
pmid:22856156
|
Iakovlev VP |
[New semisynthetic macrolides. Clarithromycin--its importance in the current therapy of bacterial infections]. |
1999 |
Antibiot. Khimioter. |
pmid:10635418
|
Evdokimova AG et al. |
[New approaches to therapy of Helicobacterpylori infection (by the materials of the Maastricht Consensus-IV, Florence, 2010)]. |
2013 |
Antibiot. Khimioter. |
pmid:24640139
|
Iakovlev VP et al. |
[Macrolide antibiotic clarithromycin (Klabax) in treatment of community-acquired respiratory tract infections]. |
2000 |
Antibiot. Khimioter. |
pmid:11210297
|
Shcherbakov PL |
[Clarithromycin in eradication therapy of helicobacter infections in children]. |
2001 |
Antibiot. Khimioter. |
pmid:11871315
|
Sazykin IuO et al. |
[Clarithromycin and tumor chemotherapy]. |
2000 |
Antibiot. Khimioter. |
pmid:11210301
|
Iutanova NS |
[Clinical efficacy of clarithromycin delayed release dosage form in the treatment of community-acquired pneumonia]. |
2004 |
Antibiot. Khimioter. |
pmid:15344392
|
Budanov SV and Vasil'ev AN |
[Clarithromycin: specific features of antimicrobial spectrum and clinical use]. |
2004 |
Antibiot. Khimioter. |
pmid:15285409
|
Guchev IA et al. |
[Evaluation of clarithromycin efficacy in the treatment of community-acquired pneumonia on the basis of the Binax NOW test results (a prospective open trial)]. |
2002 |
Antibiot. Khimioter. |
pmid:12619516
|
Aoki D et al. |
Roxithromycin inhibits angiogenesis of human hepatoma cells in vivo by suppressing VEGF production. |
|
Anticancer Res. |
pmid:15816530
|
Ohara T et al. |
Antibiotics directly induce apoptosis in B cell lymphoma cells derived from BALB/c mice. |
2004 Nov-Dec |
Anticancer Res. |
pmid:15736403
|
Geng X et al. |
The Bifunctional Enzyme SpoT Is Involved in the Clarithromycin Tolerance of Helicobacter pylori by Upregulating the Transporters HP0939, HP1017, HP0497, and HP0471. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28242673
|
Waites KB et al. |
In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2973283
|
Bolhuis MS et al. |
Clarithromycin significantly increases linezolid serum concentrations. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20837753
|
Jesus FP et al. |
In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25001300
|
Johnson MM et al. |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428903
|
Credito KL et al. |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428930
|
Bastian S et al. |
Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21135185
|
Klemens SP and Cynamon MH |
Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979271
|
Klemens SP et al. |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336945
|
Portaels F et al. |
In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9687409
|
Burucoa C et al. |
T2182C mutation is not associated with clarithromycin resistance in Helicobacter pylori. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15673794
|
Bermudez LE et al. |
EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17296742
|
Versalovic J et al. |
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8834903
|
Wallace RJ et al. |
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807061
|
Jones RN et al. |
Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20660671
|